CD19+ (B-cells), CD33+ (myeloid cells), CD34+ (hematopoietic progenitor cells)
and CD56+ (natural killer (NK) cells) cells were made by means of immunomagnetic
beads according to the manufacturer’s instructions (Dynal Biotech, Oslo,
Norway). The UCB was divided into six equal parts and immunomagnetic bead
selection was performed for one marker per UCB volume. The purity of the
positively-selected cell populations was tested by flow cytometry (not after
each cell separation), and was found to be between 90–95% pure.
DNA was extracted from cell-separated UCB, whole UCB and maternal blood using an
automatic MagNa pure machine (Roche, Basel, Switzerland). Genomic DNA
concentrations were measured using NanoDrop (Thermo Scientific, Waltham, MA,
USA).